Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
03 02 2022
Historique:
received: 22 03 2021
accepted: 01 10 2021
pubmed: 18 10 2021
medline: 8 3 2022
entrez: 17 10 2021
Statut: ppublish

Résumé

The cellular mechanisms required to ensure homeostasis of the hematopoietic niche and the ability of this niche to support hematopoiesis upon stress remain elusive. We here identify Wnt5a in Osterix+ mesenchymal progenitor and stem cells (MSPCs) as a critical factor for niche-dependent hematopoiesis. Mice lacking Wnt5a in MSPCs suffer from stress-related bone marrow (BM) failure and increased mortality. Niche cells devoid of Wnt5a show defective actin stress fiber orientation due to an elevated activity of the small GTPase CDC42. This results in incorrect positioning of autophagosomes and lysosomes, thus reducing autophagy and increasing oxidative stress. In MSPCs from patients from BM failure states which share features of peripheral cytopenia and hypocellular BM, we find similar defects in actin stress fiber orientation, reduced and incorrect colocalization of autophagosomes and lysosomes, and CDC42 activation. Strikingly, a short pharmacological intervention to attenuate elevated CDC42 activation in vivo in mice prevents defective actin-anchored autophagy in MSPCs, salvages hematopoiesis and protects against lethal cytopenia upon stress. In summary, our study identifies Wnt5a as a restriction factor for niche homeostasis by affecting CDC42-regulated actin stress-fiber orientation and autophagy upon stress. Our data further imply a critical role for autophagy in MSPCs for adequate support of hematopoiesis by the niche upon stress and in human diseases characterized by peripheral cytopenias and hypocellular BM.

Identifiants

pubmed: 34657154
pii: S0006-4971(21)01752-3
doi: 10.1182/blood.2021011775
pmc: PMC8814682
doi:

Substances chimiques

Wnt-5a Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

690-703

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 by The American Society of Hematology.

Références

Nature. 2017 Mar 9;543(7644):205-210
pubmed: 28241143
Cancer Res. 2017 Nov 1;77(21):5873-5885
pubmed: 28887323
Int J Hematol. 2015 Jan;101(1):5-12
pubmed: 25315193
Dev Cell. 2020 Jul 20;54(2):239-255
pubmed: 32693057
Br J Haematol. 2015 Jun;169(6):804-13
pubmed: 25819548
Curr Biol. 2017 Apr 24;27(8):R318-R326
pubmed: 28441569
Blood. 2021 Nov 4;138(18):1727-1732
pubmed: 34139005
Sci Rep. 2021 Mar 15;11(1):5944
pubmed: 33723276
Dev Cell. 2014 May 12;29(3):340-9
pubmed: 24823377
Blood Adv. 2018 Dec 11;2(23):3447-3461
pubmed: 30518537
Br J Haematol. 2018 Jul;182(1):114-124
pubmed: 29767474
Nature. 2021 Mar;591(7848):117-123
pubmed: 33442062
J Mol Biol. 2020 Apr 3;432(8):2525-2545
pubmed: 31972172
Blood. 2018 Sep 20;132(12):1318-1331
pubmed: 29914977
Cell Stem Cell. 2014 Jun 5;14(6):824-37
pubmed: 24704494
Stem Cell Reports. 2015 Nov 10;5(5):702-715
pubmed: 26527384
Stem Cells. 2017 Jul;35(7):1835-1848
pubmed: 28480607
Science. 2012 Oct 5;338(6103):108-13
pubmed: 22956684
J Exp Med. 2017 Jan;214(1):165-181
pubmed: 27998927
Development. 2006 Aug;133(16):3231-44
pubmed: 16854976
Aging Cell. 2020 Sep;19(9):e13208
pubmed: 32755011
Chem Biol. 2006 Apr;13(4):443-52
pubmed: 16632257
Autophagy. 2015;11(9):1652-67
pubmed: 26103419
Cancer Discov. 2014 Apr;4(4):466-79
pubmed: 24513958
Nature. 2013 Feb 21;494(7437):323-7
pubmed: 23389440
Nat Commun. 2020 Dec 1;11(1):6146
pubmed: 33262376
Autophagy. 2015;11(3):560-72
pubmed: 25714620
Leukemia. 2019 Mar;33(3):749-761
pubmed: 30254339
Cell Stem Cell. 2020 Mar 5;26(3):420-430.e6
pubmed: 32059807
Am J Respir Cell Mol Biol. 2017 Mar;56(3):300-309
pubmed: 27636016
J Clin Invest. 2012 Mar;122(3):1052-65
pubmed: 22354172
Cell Stem Cell. 2016 Nov 3;19(5):613-627
pubmed: 27666011
Biochem Biophys Res Commun. 2018 Jul 2;501(4):941-947
pubmed: 29772235
Expert Opin Drug Discov. 2015;10(9):991-1010
pubmed: 26087073
Front Cell Dev Biol. 2021 Mar 12;9:622519
pubmed: 33777933
Haematologica. 2009 Mar;94(3):409-13
pubmed: 19211642
Biomaterials. 2019 May;203:96-110
pubmed: 29980291
Nature. 2013 Nov 21;503(7476):392-6
pubmed: 24141946
Int J Biochem Cell Biol. 2012 Jun;44(6):989-97
pubmed: 22465708
Exp Hematol. 1985 Mar;13(3):194-9
pubmed: 3884357
Cell Stem Cell. 2012 May 4;10(5):520-30
pubmed: 22560076
Mol Cell. 2019 Jan 17;73(2):364-376.e8
pubmed: 30581142
Front Immunol. 2018 Apr 09;9:679
pubmed: 29686674
Blood. 2019 Mar 7;133(10):1031-1038
pubmed: 30670448
Blood. 2010 Sep 2;116(9):1422-32
pubmed: 20472830
Nature. 2019 Sep;573(7774):426-429
pubmed: 31485073
Cell Stem Cell. 2020 Mar 5;26(3):359-376.e7
pubmed: 32109377
Nat Protoc. 2010 Mar;5(3):550-60
pubmed: 20203670
J Biol Chem. 2013 Mar 22;288(12):8531-8543
pubmed: 23382385
Life Sci. 2019 Jul 15;229:36-45
pubmed: 31085242
Nat Rev Immunol. 2013 May;13(5):376-89
pubmed: 23584423
Nat Cell Biol. 2019 Nov;21(11):1309-1320
pubmed: 31685996
Blood. 2021 Apr 28;:
pubmed: 33908607
Nat Commun. 2016 Sep 30;7:12886
pubmed: 27686185

Auteurs

Theresa Landspersky (T)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Mehmet Saçma (M)

Institute of Molecular Medicine, Ulm University, Ulm, Germany.

Jennifer Rivière (J)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Judith S Hecker (JS)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Franziska Hettler (F)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Erik Hameister (E)

TUM, School of Medicine, Clinical Chemistry and Pathobiochemistry, Munich, Germany.

Katharina Brandstetter (K)

Human Biology and BioImaging, Faculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany.

Rouzanna Istvánffy (R)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Sandra Romero Marquez (S)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Romina Ludwig (R)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Marilena Götz (M)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Michèle Buck (M)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Martin Wolf (M)

Institute of Experimental and Clinical Cell Therapy, Paracelsus University Salzburg, Salzburg, Austria.

Matthias Schiemann (M)

TUM, Institute for Medical Microbiology, Immunology and Hygiene, CyTUM-MIH, Munich, Germany.

Jürgen Ruland (J)

TUM, School of Medicine, Clinical Chemistry and Pathobiochemistry, Munich, Germany.

Dirk Strunk (D)

Institute of Experimental and Clinical Cell Therapy, Paracelsus University Salzburg, Salzburg, Austria.

Akiko Shimamura (A)

Bone Marrow Failure and MDS Program, Dana Farber and Boston Children's Hospital, Boston, MA.

Kasiani Myers (K)

Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Terry P Yamaguchi (TP)

Cancer and Developmental Biology Laboratory, Center for Cancer Research, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD.

Matthias Kieslinger (M)

Department for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria; and.

Heinrich Leonhardt (H)

Human Biology and BioImaging, Faculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany.

Florian Bassermann (F)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Katharina S Götze (KS)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Hartmut Geiger (H)

Institute of Molecular Medicine, Ulm University, Ulm, Germany.

Christina Schreck (C)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Robert A J Oostendorp (RAJ)

Technical University of Munich (TUM), School of Medicine, Department of Internal Medicine III, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH